Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH

被引:42
作者
Lindholm, P. M. [1 ]
Salmenkivi, K. [1 ]
Vauhkonen, H. [1 ]
Nicholson, A. G. [2 ]
Anttila, S. [3 ]
Kinnula, V. L. [4 ]
Knuutila, S. [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Haartman Inst, HUSLAB,Dept Pathol, FIN-00014 Helsinki, Finland
[2] Royal Brompton Hosp, Dept Histopathol, London, England
[3] Finnish Inst Occupant Hlth, Helsinki, Finland
[4] Univ Helsinki, Univ Hosp Helsinki, Dept Med, Pulm Div, FIN-00014 Helsinki, Finland
关键词
D O I
10.1159/000109618
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Conventional cytogenetic analyses and comparative genomic hybridization have revealed a complex and even chaotic nature of chromosomal aberrations in pleural malignant mesothelioma (MM). We set out to describe the complex gene copy number changes and screen for novel genetic aberrations using a high-density oligonucleotide microarray platform for comparative genomic hybridization (aCGH) of a series of 26 well-characterized MM tumor samples. The number of copy number changes varied from zero to 40 per sample. Gene copy number losses predominated over gains, and the most frequent region of loss was 9p21.3 (17/26 cases), the locus of CDKN2A and CDKN2B, both known to be commonly lost in MM. The most recurrent minimal regions of losses were 1p31.1 -> p13.2, 3p22.1 -> p14.2, 6q22.1, 9p21.3, 13cen -> q14.12, 14q22.1 -> qter, and 22qcen -> q12.3. Previously unreported gains included 9p13.3, 7p22.3 -> p22.2, 12q13.3, and 17q21.32 -> qter. The results suggest that gene copy number losses are a major mechanism of MM carcinogenesis and reveal a recurrent pattern of copy number changes in MM. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 44 条
[11]   RECURRING LOSS INVOLVING CHROMOSOME-1, CHROMOSOME-3, AND CHROMOSOME-22 IN MALIGNANT MESOTHELIOMA - POSSIBLE SITES OF TUMOR SUPPRESSOR GENES [J].
FLEJTER, WL ;
LI, FP ;
ANTMAN, KH ;
TESTA, JR .
GENES CHROMOSOMES & CANCER, 1989, 1 (02) :148-154
[12]   FRA3B and other common fragile sites:: The weakest links [J].
Huebner, K ;
Croce, CM .
NATURE REVIEWS CANCER, 2001, 1 (03) :214-221
[13]   The role of the FHIT/FRA3B locus in cancer [J].
Huebner, K ;
Garrison, PN ;
Barnes, LD ;
Croce, CM .
ANNUAL REVIEW OF GENETICS, 1998, 32 :7-31
[14]  
Illei PB, 2003, CLIN CANCER RES, V9, P2108
[15]   Fhit modulates the DNA damage checkpoint response [J].
Ishii, Hideshi ;
Mimori, Koshi ;
Inoue, Hiroshi ;
Inageta, Taeko ;
Ishikawa, Kazuhiro ;
Semba, Shuho ;
Druck, Teresa ;
Trapasso, Francesco ;
Tani, Kenzaburo ;
Vecchione, Andrea ;
Croce, Carlo M. ;
Mori, Masaki ;
Huebner, Kay .
CANCER RESEARCH, 2006, 66 (23) :11287-11292
[16]  
Jensen RH, 2003, ANTICANCER RES, V23, P2281
[17]  
Kaiser LR, 1999, J THORAC CARDIOV SUR, V117, P63
[18]   Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization [J].
Kivipensas, P ;
Bjorkqvist, AM ;
Karhu, R ;
Pelin, K ;
Linnainmaa, K ;
Tammilehto, L ;
Mattson, K ;
Kallioniemi, OP ;
Knuutila, S .
CANCER GENETICS AND CYTOGENETICS, 1996, 89 (01) :7-13
[19]  
KNUUTTILA A, 2005, VIRCHOWS ARCH, V448, P1
[20]   Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer:: Deduction from structural analysis of breakpoints for deletions [J].
Kohno, Takashi ;
Yokota, Jun .
DNA REPAIR, 2006, 5 (9-10) :1273-1281